newsfilter
← Latest News
GlobeNewswire·

Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements

HOUSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) (Salarius or the Company) announces that on October 10, 2025 the Company received notice from the Nasdaq Stock Market LLC (Nasdaq)